Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 6/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | ASPH | Q12797 | 1/20 | 0.38 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7257808 | 0.91 | PTGDR2 (0.44) | SLC6A4SLC6A2SLC6A3APOBEC3GCYP2A6 | |
| SCHEMBL477417 | 0.90 | PTGDR2 (0.46) | SLC6A4SLC6A2SLC6A3APOBEC3GCYP2A6 | |
| SCHEMBL12835831 | 0.86 | SLC6A2 (0.59) | SLC6A4SLC6A2SLC6A3HTR1AHTR2C | |
| SCHEMBL29805150 | 0.86 | SLC6A2 (0.59) | SLC6A4SLC6A2SLC6A3HTR1AHTR2C | |
| Hydrochloric Acid SCHEMBL6075750 | 0.85 | SLC6A2 (0.58) | SLC6A4SLC6A2SLC6A3HTR1AHTR2C | |
| SCHEMBL10297984 | 0.83 | MEN1 (0.40) | SLC6A4SLC6A2SLC6A3MEN1KMT2A | |
| SCHEMBL11989014 | 0.83 | MEN1 (0.38) | SLC6A4SLC6A2SLC6A3HTR1AMEN1 | |
| SCHEMBL5140978 | 0.83 | DRD2 (0.44) | SLC6A4MEN1KMT2ADRD2 | |
| SCHEMBL8452032 | 0.83 | CYP2C9 (0.42) | SLC6A4SLC6A2SLC6A3MEN1KMT2A | |
| SCHEMBL5383496 | 0.83 | APOBEC3G (0.39) | SLC6A4SLC6A2SLC6A3APOBEC3GCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004111092-A1 | MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-12-23 | — | — | WO | claimed |
| JP-62205038-A | — | — | None | — | — | JP | disclosed |
| WO-2023185811-A1 | NOVEL HETEROCYCLIC COMPOUND | 首药控股(北京)股份有限公司 | 2023-10-05 | — | — | WO | disclosed |
| CN-115448882-A | Benzoheterocyclic compounds useful for the treatment of EP2, EP4 receptor mediated diseases | 武汉人福创新药物研发中心有限公司 | 2022-12-09 | — | — | CN | disclosed |
| EP-3737684-B1 | 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-11-16 | — | — | EP | disclosed |
| CN-109689667-B | Porous chiral material and use thereof | 南开大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-110114351-A | The heterocycle inhibitor of MCT4 | 维托尔股份有限公司 | 2019-08-09 | — | — | CN | disclosed |
| CN-105566197-A | Synthesis method of tetrahydropyrrole derivatives | UNIV NANJING FORESTRY | 2016-05-11 | — | — | CN | disclosed |
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| US-7169954-B2 | Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20060094899-A1 | Process for preparing ruthenium-carrying alumina and process for oxidizing alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED | 2006-05-04 | — | — | US | disclosed |
| US-6878838-B2 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-04-12 | — | — | US | disclosed |
| EP-1500432-A1 | METHOD FOR PREPARING RUTHENIUM-CARRYING ALUMINA AND METHOD FOR OXIDIZING ALCOHOL | Sumitomo Chemical Company, Limited (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20040204597-A1 | Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-10-14 | — | — | US | disclosed |
| WO-2004084834-A2 | CHIRAL POROUS METAL PHOSPHONATES FOR HETEROGENEOUS ASYMMETRIC CATALYSIS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | NORTH CAROLINA AT CHAPEL HILL, UNIVERSITY OF, THE | 2004-09-30 | — | — | US | disclosed |
| EP-0682663-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1994018188-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | THE UPJOHN COMPANY (US) | 1994-08-18 | — | — | WO | disclosed |
| JP-S62205038-A | PRODUCTION OF 4-FLUORO-1-BUTENE DERIVATIVE | RIKAGAKU KENKYUSHO | 1987-09-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094899-A1 | Process for preparing ruthenium-carrying alumina and process for oxidizing alcohol | ADH1A, ADH5, ADH7 | SLC6A4 3464/4885SLC6A2 2586/4885SLC6A3 3657/4885 |
| US-20040204597-A1 | Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol | ADH1A, ADH7, ADH5 | SLC6A4 3542/4885SLC6A2 2311/4885SLC6A3 3364/4885 |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | SLC6A4 2886/4885SLC6A2 3969/4885SLC6A3 2874/4885 |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | ZKSCAN2, TPRKB, KHK | SLC6A4 2623/4885SLC6A2 4614/4885SLC6A3 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.